{
  "compound": "Oral THC",
  "condition": "GLAUCOMA",
  "effect_size": "Dose-dependent (18-28%)",
  "study_type": "RCT",
  "source": "NORML:GLAUCOMA_RCT_005",
  "participants": "18 glaucoma patients",
  "year": 1981,
  "notes": "Oral Delta-9-THC for Glaucoma: Dose-Response Study",
  "confidence": "medium",
  "abstract": "5mg: 18% IOP reduction; 10mg: 24% IOP reduction; 20mg: 28% IOP reduction; Clear dose-response relationship"
}